HANDELNINE GLOBAL LLC: Drug Recall

Recall #D-0332-2026 · 12/22/2025

Class I: Dangerous

Recall Details

Recall Number
D-0332-2026
Classification
Class I
Product Type
Drug
Recalling Firm
HANDELNINE GLOBAL LLC
Status
Ongoing
Date Initiated
12/22/2025
Location
South Plainfield, NJ, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4 bottles /30 capsules each

Reason for Recall

CGMP Deviations: product found to contain lead.

Product Description

Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313

Distribution Pattern

Product was distributed to one customer in NY.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.